NORTH AMERICA STEM CELL MARKET FORECAST 2017-2025
KEY FINDINGS
The North America Stem cell market is estimated at $ 2695 million in the year 2016 and expected to reach $ 6210 million in the year 2025 at a CAGR of 9.62% during the forecast period 2017-2025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The government’s subsidy and sustenance in the field of stem cell market, increasing investments in R&D and surge in neurodegenerative ailments are some of the factors driving the stem cell market. Also, improvements in the implementation of stem cell, good growth in medical tourism and an enlarged stem cell banking are the dominant drivers in the stem cell market.
MARKET INSIGHTS
Stem cell market is segmented by products, by technology, by production market, and by the application. The stem cell market by products is segmented on the basis of Adult Stem cell market and human embryonic stem cell market. The adult stem cell market is further divided into Hematopoietic stem cell market, Mesenchymal stem cell market, Neural stem cell market, dental stem cell market and umbilical cord stem cell market. Human embryonic stem cell market is further divided into induced pluripotent stem cell market and RAT Neural Stem Cell market. The Stem cell market by technology is segmented on the basis of Stem cell acquisition market, stem cell production market, Stem cell Cryopreservation market, stem cell expansion and subculture market. The stem cell market by application is further divided into stem cell regenerative medicine market and drug discovery and development market.
COMPETITIVE INSIGHTS
Major players for the Stem Cell market are Celgene corporation Fibrocell science, Cellartis AB (acquired by Takara holdings Inc.), GE Healthcare, Thermo fisher scientific Pvt Ltd, Stem cell technologies, Cellular dynamics international (holding company Fujifilm), Vericel corporation (Aastrom bioscience), Brainstorm cell therapeutics, Cytori therapeutics Inc California stem cell Inc. (Holding company Caladrius biosciences, Inc. ), Beckton Dickinson and company, Biotime Inc., Stryker corporation,. Some major companies involved in stem cell are; GE Healthcare, Stem cell technology, Thermo Fisher, Becton, Corning and many others.
The North America Stem cell market is estimated at $ 2695 million in the year 2016 and expected to reach $ 6210 million in the year 2025 at a CAGR of 9.62% during the forecast period 2017-2025. The base year considered for the study is 2016 and the forecast period is between 2017 and 2025. The government’s subsidy and sustenance in the field of stem cell market, increasing investments in R&D and surge in neurodegenerative ailments are some of the factors driving the stem cell market. Also, improvements in the implementation of stem cell, good growth in medical tourism and an enlarged stem cell banking are the dominant drivers in the stem cell market.
MARKET INSIGHTS
Stem cell market is segmented by products, by technology, by production market, and by the application. The stem cell market by products is segmented on the basis of Adult Stem cell market and human embryonic stem cell market. The adult stem cell market is further divided into Hematopoietic stem cell market, Mesenchymal stem cell market, Neural stem cell market, dental stem cell market and umbilical cord stem cell market. Human embryonic stem cell market is further divided into induced pluripotent stem cell market and RAT Neural Stem Cell market. The Stem cell market by technology is segmented on the basis of Stem cell acquisition market, stem cell production market, Stem cell Cryopreservation market, stem cell expansion and subculture market. The stem cell market by application is further divided into stem cell regenerative medicine market and drug discovery and development market.
COMPETITIVE INSIGHTS
Major players for the Stem Cell market are Celgene corporation Fibrocell science, Cellartis AB (acquired by Takara holdings Inc.), GE Healthcare, Thermo fisher scientific Pvt Ltd, Stem cell technologies, Cellular dynamics international (holding company Fujifilm), Vericel corporation (Aastrom bioscience), Brainstorm cell therapeutics, Cytori therapeutics Inc California stem cell Inc. (Holding company Caladrius biosciences, Inc. ), Beckton Dickinson and company, Biotime Inc., Stryker corporation,. Some major companies involved in stem cell are; GE Healthcare, Stem cell technology, Thermo Fisher, Becton, Corning and many others.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
4. MARKET DETERMINANTS
4.1. MARKET DRIVER
4.1.1. UPSURGE IN NEURODEGENERATIVE AILMENTS
4.1.2. INVESTMENTS IN R&D IS GROWING
4.1.3. GOVERNMENT SUBSIDY AND SUSTENANCE
4.1.4. ADVANCEMENTS IN THE APPLICATIONS OF STEM CELL
4.1.5. SIGNIFICANT GROWTH IN MEDICAL TOURISM
4.1.6. SWELLING STEM CELL BANKING
4.2. MARKET RESTRAINTS
4.2.1. STEM CELL TREATMENT INCURS HUGE COST
4.2.2. AVERSION IN REIMBURSEMENT POLICIES
4.3. MARKET OPPORTUNITIES
4.3.1. RISING INVESTMENT IN THE STEM CELL MARKET
4.3.2. REPLACED THE USE OF ANIMAL TISSUES FOR THE EXPERIMENTS
4.3.3. GROWING INCOME OF THE PEOPLE ALL ACROSS THE WORLD
4.3.4. CONTINUE SUPPORT OF CONTRACT RESEARCH INDUSTRY
4.4. MARKET CHALLENGES
4.4.1. STRINGENT GOVERNMENT REGULATIONS
4.4.2. FEWER RESPONSIVENESS IN THE DEVELOPED ECONOMIES
5. MARKET SEGMENTATION
5.1. BY PRODUCTS
5.1.1. ADULT STEM CELL MARKET
5.1.1.1. HEMATOPOIETIC STEM CELL MARKET
5.1.1.2. MESENCHYMAL STEM CELL MARKET
5.1.1.3. NEURAL STEM CELL MARKET
5.1.1.4. DENTAL STEM CELL MARKET
5.1.1.5. UMBILICAL CORD STEM CELL MARKET
5.1.2. HUMAN EMBRYONIC STEM CELL
5.1.3. INDUCED PLURIPOTENT STEM CELL MARKET
5.1.4. RAT NEURAL STEM CELL MARKET
5.2. BY TECHNOLOGY
5.2.1. STEM CELL ACQUISITION MARKET
5.2.1.1. STEM CELL BONE MARROW MARKET
5.2.1.2. STEM CELL APHERESIS MARKET
5.2.1.3. STEM CELL UMBILICAL CORD BLOOD MARKET
5.2.2. STEM CELL PRODUCTION MARKET
5.2.2.1. THERAPEUTIC CLONING FOR STEM CELL MARKET
5.2.2.2. IVF STEM CELL MARKET
5.2.2.3. STEM CELL CULTURE MARKET
5.2.3. STEM CELL CRYOPRESERVATION MARKET
5.2.4. STEM CELLS EXPANSION AND SUB-CULTURE MARKET
5.3. STEM CELLS MARKET BY APPLICATION
5.3.1. STEM CELLS REGENERATIVE MEDICINE MARKET
5.3.2. DRUG DISCOVERY AND DEVELOPMENT MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. VALUE CHAIN ANALYSIS
6.4. OPPORTUNITY MATRIX
6.5. KEY BUYING CRITERIA
6.5.1. HIGH PRICE
6.5.2. EFFICACY
6.5.3. APPLICATION AND EFFECTIVENESS
6.5.4. ACCURACY
6.6. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.7. VENDOR LANDSCAPE
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA STEM CELL MARKET
7.1.1. US STEM CELL MARKET
7.1.2. CANADA STEM CELL MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.1.1. TOP WINNING STRATEGIES
9. COMPANY PROFILE
9.1. CYTORI THERAPEUTICS INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. FIBROCELL SCIENCE
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. CELLARTIS AB (ACQUIRED BY TAKARA HOLDINGS INC.)
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVES
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. BIOTIME INC.
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. SCOT ANALYSIS
9.4.4. STRATEGIC ANALYSIS
9.5. GE HEALTHCARE
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. THERMO FISHER SCIENTIFIC PVT. LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. STEMCELL TECHNOLOGIES
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. VERICEL CORPORATION (AASTROM BIOSCIENCE)
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. BRAINSTORM CELL THERAPEUTICS
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. CALIFORNIA STEM CELL INC. (HOLDING COMPANY CALADRIUS BIOSCIENCES, INC)
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGICINITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGICANALYSIS
9.12. BECKTON DICKINSON AND COMPANY
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT
9.12.4. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.2. PRODUCTPORTFOLIO
9.13.3. SCOT
9.13.4. STRATEGICANALYSIS
9.14. CORNING INC.
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. SCOT ANALYSIS
9.14.4. STRATEGIC ANALYSIS
9.15. CELGENE CORPORATION
9.15.1. OVERVIEW
9.15.2. PRODUCTPORTFOLIO
9.15.3. STRATEGIC INITIATIVE
9.15.4. SCOT ANALYSIS
9.15.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 NORTH AMERICA STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
TABLE 2 ADULT STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 3 NORTH AMERICA STEM CELL MARKET IN HEMATOPOITIC STEM CELL 2017-2025 ($ MILLION)
TABLE 4 NORTH AMERICA STEM CELL MARKET IN MESENCHYMAL STEM CELL 2017-2025 ($ MILLION)
TABLE 5 NORTH AMERICA STEM CELL MARKET IN NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 6 NORTH AMERICA STEM CELL MARKET IN DENTAL STEM CELL 2017-2025 ($ MILLION)
TABLE 7 NORTH AMERICA STEM CELL MARKET IN UMBILICAL CORD STEM CELL 2017-2025 ($ MILLION)
TABLE 8 NORTH AMERICA STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
TABLE 9 NORTH AMERICA STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
TABLE 10 NORTH AMERICA STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 11 NORTH AMERICA STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
TABLE 12 NORTH AMERICA STEM CELL ACQUISITION MARKET 2017-2025 ($ MILLION)
TABLE 13 NORTH AMERICA STEM CELL BONE MARROW MARKET BY REGIONS 2017-2025 ($ MILLION)
TABLE 14 NORTH AMERICA STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)
TABLE 15 NORTH AMERICA STEM CELL UMBLICAL CORD BLOOD MARKET BY REGIONS 2017-2025 ($ MILLION)
TABLE 16 NORTH AMERICA STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
TABLE 17 NORTH AMERICA STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
TABLE 18 NORTH AMERICA STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)
TABLE 19 NORTH AMERICA IVF STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 20 NORTH AMERICA STEM CELL CULTURE MARKET 2017-2025 ($ MILLION)
TABLE 21 NORTH AMERICA STEM CELL CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)
TABLE 22 NORTH AMERICA STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)
TABLE 23 NORTH AMERICA STEM CELLS MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 24 NORTH AMERICA STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)
TABLE 25 NEW CANCER CASES BY SEX, US, 2016
TABLE 26 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
TABLE 27 NORTH AMERICA STEM CELL MARKET BY REGION 2017-2025($ MILLION)
FIGURES LIST
FIGURE 1 NORTH AMERICA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 2 KEY FINDINGS OF STEM CELL MARKET
FIGURE 3 AGES OF PEOPLE WITH ALZHEIMER’S DISEASE IN THE UNITED STATES, 2016
FIGURE 4 NIH SPENDING ON STEM CELL RESEARCH BY YEAR 2013-2016 IN USD $BILLION
FIGURE 5 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 6 US DISPOSABLE PERSONAL INCOME IN USD BILLIONS
FIGURE 7 NORTH AMERICA STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
FIGURE 8 NORTH AMERICA STEM CELLS MARKET IN ADULT STEM CELL 2017-2025 ($ MILLION)
FIGURE 9 NORTH AMERICA STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
FIGURE 10 NORTH AMERICA STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
FIGURE 11 NORTH AMERICA STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
FIGURE 12 NORTH AMERICA STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
FIGURE 13 NORTH AMERICA STEM CELL MARKET BY ACQUISITION 2017-2025 ($ MILLION)
FIGURE 14 NORTH AMERICA STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)
FIGURE 15 NORTH AMERICA STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)
FIGURE 16 NORTH AMERICA STEM CELL UMBILICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)
FIGURE 17 NORTH AMERICA STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
FIGURE 18 NORTH AMERICA STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)
FIGURE 19 NORTH AMERICA IVF STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 20 NORTH AMERICA STEM CELLS CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 21 NORTH AMERICA STEM CELLS CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)
FIGURE 22 NORTH AMERICA STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 23 NORTH AMERICA STEM CELLS MARKET BY APPLICATION 2017 & 2025 ($ MILLION)
FIGURE 24 NORTH AMERICA STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)
FIGURE 25 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
FIGURE 26 GEOGRAPHIC OUTLOOK 2016 & 2025 (%)
FIGURE 27 ESTIMATED NUMBER OF NOVEL CANCER CASES AND DEATHS BY GENDER IN THE U.S., 2016
FIGURE 28 NORTH AMERICA STEM CELL MARKET BY COUNTRIES 2016 & 2025 ($ MILLION)
FIGURE 29 NORTH AMERICA STEM CELL REGIONAL MARKET BREAKDOWN IN 2016 (%)
FIGURE 30 UNITED STATES (U.S.) STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 31 ESTIMATED CASES OF CANCER IN CANADA 2015
FIGURE 32 CANADA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 33 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
2.5. ESTIMATION METHODOLOGY
3. EXECUTIVE SUMMARY
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
4. MARKET DETERMINANTS
4.1. MARKET DRIVER
4.1.1. UPSURGE IN NEURODEGENERATIVE AILMENTS
4.1.2. INVESTMENTS IN R&D IS GROWING
4.1.3. GOVERNMENT SUBSIDY AND SUSTENANCE
4.1.4. ADVANCEMENTS IN THE APPLICATIONS OF STEM CELL
4.1.5. SIGNIFICANT GROWTH IN MEDICAL TOURISM
4.1.6. SWELLING STEM CELL BANKING
4.2. MARKET RESTRAINTS
4.2.1. STEM CELL TREATMENT INCURS HUGE COST
4.2.2. AVERSION IN REIMBURSEMENT POLICIES
4.3. MARKET OPPORTUNITIES
4.3.1. RISING INVESTMENT IN THE STEM CELL MARKET
4.3.2. REPLACED THE USE OF ANIMAL TISSUES FOR THE EXPERIMENTS
4.3.3. GROWING INCOME OF THE PEOPLE ALL ACROSS THE WORLD
4.3.4. CONTINUE SUPPORT OF CONTRACT RESEARCH INDUSTRY
4.4. MARKET CHALLENGES
4.4.1. STRINGENT GOVERNMENT REGULATIONS
4.4.2. FEWER RESPONSIVENESS IN THE DEVELOPED ECONOMIES
5. MARKET SEGMENTATION
5.1. BY PRODUCTS
5.1.1. ADULT STEM CELL MARKET
5.1.1.1. HEMATOPOIETIC STEM CELL MARKET
5.1.1.2. MESENCHYMAL STEM CELL MARKET
5.1.1.3. NEURAL STEM CELL MARKET
5.1.1.4. DENTAL STEM CELL MARKET
5.1.1.5. UMBILICAL CORD STEM CELL MARKET
5.1.2. HUMAN EMBRYONIC STEM CELL
5.1.3. INDUCED PLURIPOTENT STEM CELL MARKET
5.1.4. RAT NEURAL STEM CELL MARKET
5.2. BY TECHNOLOGY
5.2.1. STEM CELL ACQUISITION MARKET
5.2.1.1. STEM CELL BONE MARROW MARKET
5.2.1.2. STEM CELL APHERESIS MARKET
5.2.1.3. STEM CELL UMBILICAL CORD BLOOD MARKET
5.2.2. STEM CELL PRODUCTION MARKET
5.2.2.1. THERAPEUTIC CLONING FOR STEM CELL MARKET
5.2.2.2. IVF STEM CELL MARKET
5.2.2.3. STEM CELL CULTURE MARKET
5.2.3. STEM CELL CRYOPRESERVATION MARKET
5.2.4. STEM CELLS EXPANSION AND SUB-CULTURE MARKET
5.3. STEM CELLS MARKET BY APPLICATION
5.3.1. STEM CELLS REGENERATIVE MEDICINE MARKET
5.3.2. DRUG DISCOVERY AND DEVELOPMENT MARKET
6. KEY ANALYTICS
6.1. PORTER’S FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS OR SERVICES
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. PESTEL ANALYSIS
6.3. VALUE CHAIN ANALYSIS
6.4. OPPORTUNITY MATRIX
6.5. KEY BUYING CRITERIA
6.5.1. HIGH PRICE
6.5.2. EFFICACY
6.5.3. APPLICATION AND EFFECTIVENESS
6.5.4. ACCURACY
6.6. STRATEGIC RECOMMENDATION & STRATEGIC CONCLUSIONS
6.7. VENDOR LANDSCAPE
7. GEOGRAPHICAL ANALYSIS
7.1. NORTH AMERICA STEM CELL MARKET
7.1.1. US STEM CELL MARKET
7.1.2. CANADA STEM CELL MARKET
8. COMPETITIVE LANDSCAPE
8.1. MARKET SHARE ANALYSIS
8.1.1. TOP WINNING STRATEGIES
9. COMPANY PROFILE
9.1. CYTORI THERAPEUTICS INC.
9.1.1. OVERVIEW
9.1.2. PRODUCT PORTFOLIO
9.1.3. SCOT ANALYSIS
9.1.4. STRATEGIC ANALYSIS
9.2. FIBROCELL SCIENCE
9.2.1. OVERVIEW
9.2.2. PRODUCT PORTFOLIO
9.2.3. STRATEGIC INITIATIVES
9.2.4. SCOT ANALYSIS
9.2.5. STRATEGIC ANALYSIS
9.3. CELLARTIS AB (ACQUIRED BY TAKARA HOLDINGS INC.)
9.3.1. OVERVIEW
9.3.2. PRODUCT PORTFOLIO
9.3.3. STRATEGIC INITIATIVES
9.3.4. SCOT ANALYSIS
9.3.5. STRATEGIC ANALYSIS
9.4. BIOTIME INC.
9.4.1. OVERVIEW
9.4.2. PRODUCT PORTFOLIO
9.4.3. SCOT ANALYSIS
9.4.4. STRATEGIC ANALYSIS
9.5. GE HEALTHCARE
9.5.1. OVERVIEW
9.5.2. PRODUCT PORTFOLIO
9.5.3. STRATEGIC INITIATIVES
9.5.4. SCOT ANALYSIS
9.5.5. STRATEGIC ANALYSIS
9.6. THERMO FISHER SCIENTIFIC PVT. LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT PORTFOLIO
9.6.3. STRATEGIC INITIATIVE
9.6.4. SCOT ANALYSIS
9.6.5. STRATEGIC ANALYSIS
9.7. STEMCELL TECHNOLOGIES
9.7.1. OVERVIEW
9.7.2. PRODUCT PORTFOLIO
9.7.3. STRATEGIC INITIATIVES
9.7.4. SCOT ANALYSIS
9.7.5. STRATEGIC ANALYSIS
9.8. CELLULAR DYNAMICS INTERNATIONAL (HOLDING COMPANY FUJIFILM)
9.8.1. OVERVIEW
9.8.2. PRODUCT PORTFOLIO
9.8.3. STRATEGIC INITIATIVES
9.8.4. SCOT ANALYSIS
9.8.5. STRATEGIC ANALYSIS
9.9. VERICEL CORPORATION (AASTROM BIOSCIENCE)
9.9.1. OVERVIEW
9.9.2. PRODUCT PORTFOLIO
9.9.3. STRATEGIC INITIATIVES
9.9.4. SCOT ANALYSIS
9.9.5. STRATEGIC ANALYSIS
9.10. BRAINSTORM CELL THERAPEUTICS
9.10.1. OVERVIEW
9.10.2. PRODUCT PORTFOLIO
9.10.3. SCOT ANALYSIS
9.10.4. STRATEGIC ANALYSIS
9.11. CALIFORNIA STEM CELL INC. (HOLDING COMPANY CALADRIUS BIOSCIENCES, INC)
9.11.1. OVERVIEW
9.11.2. PRODUCT PORTFOLIO
9.11.3. STRATEGICINITIATIVES
9.11.4. SCOT ANALYSIS
9.11.5. STRATEGICANALYSIS
9.12. BECKTON DICKINSON AND COMPANY
9.12.1. OVERVIEW
9.12.2. PRODUCT PORTFOLIO
9.12.3. SCOT
9.12.4. STRATEGIC ANALYSIS
9.13. STRYKER CORPORATION
9.13.1. OVERVIEW
9.13.2. PRODUCTPORTFOLIO
9.13.3. SCOT
9.13.4. STRATEGICANALYSIS
9.14. CORNING INC.
9.14.1. OVERVIEW
9.14.2. PRODUCT PORTFOLIO
9.14.3. SCOT ANALYSIS
9.14.4. STRATEGIC ANALYSIS
9.15. CELGENE CORPORATION
9.15.1. OVERVIEW
9.15.2. PRODUCTPORTFOLIO
9.15.3. STRATEGIC INITIATIVE
9.15.4. SCOT ANALYSIS
9.15.5. STRATEGIC ANALYSIS
TABLE LIST
TABLE 1 NORTH AMERICA STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
TABLE 2 ADULT STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 3 NORTH AMERICA STEM CELL MARKET IN HEMATOPOITIC STEM CELL 2017-2025 ($ MILLION)
TABLE 4 NORTH AMERICA STEM CELL MARKET IN MESENCHYMAL STEM CELL 2017-2025 ($ MILLION)
TABLE 5 NORTH AMERICA STEM CELL MARKET IN NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 6 NORTH AMERICA STEM CELL MARKET IN DENTAL STEM CELL 2017-2025 ($ MILLION)
TABLE 7 NORTH AMERICA STEM CELL MARKET IN UMBILICAL CORD STEM CELL 2017-2025 ($ MILLION)
TABLE 8 NORTH AMERICA STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
TABLE 9 NORTH AMERICA STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
TABLE 10 NORTH AMERICA STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
TABLE 11 NORTH AMERICA STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
TABLE 12 NORTH AMERICA STEM CELL ACQUISITION MARKET 2017-2025 ($ MILLION)
TABLE 13 NORTH AMERICA STEM CELL BONE MARROW MARKET BY REGIONS 2017-2025 ($ MILLION)
TABLE 14 NORTH AMERICA STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)
TABLE 15 NORTH AMERICA STEM CELL UMBLICAL CORD BLOOD MARKET BY REGIONS 2017-2025 ($ MILLION)
TABLE 16 NORTH AMERICA STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
TABLE 17 NORTH AMERICA STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
TABLE 18 NORTH AMERICA STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)
TABLE 19 NORTH AMERICA IVF STEM CELL MARKET 2017-2025 ($ MILLION)
TABLE 20 NORTH AMERICA STEM CELL CULTURE MARKET 2017-2025 ($ MILLION)
TABLE 21 NORTH AMERICA STEM CELL CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)
TABLE 22 NORTH AMERICA STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)
TABLE 23 NORTH AMERICA STEM CELLS MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 24 NORTH AMERICA STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)
TABLE 25 NEW CANCER CASES BY SEX, US, 2016
TABLE 26 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
TABLE 27 NORTH AMERICA STEM CELL MARKET BY REGION 2017-2025($ MILLION)
FIGURES LIST
FIGURE 1 NORTH AMERICA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 2 KEY FINDINGS OF STEM CELL MARKET
FIGURE 3 AGES OF PEOPLE WITH ALZHEIMER’S DISEASE IN THE UNITED STATES, 2016
FIGURE 4 NIH SPENDING ON STEM CELL RESEARCH BY YEAR 2013-2016 IN USD $BILLION
FIGURE 5 NIH SPENDING ON STEM CELL, BY YEARS (USD BILLIONS)
FIGURE 6 US DISPOSABLE PERSONAL INCOME IN USD BILLIONS
FIGURE 7 NORTH AMERICA STEM CELLS MARKET BY PRODUCTS 2017-2025 ($ MILLION)
FIGURE 8 NORTH AMERICA STEM CELLS MARKET IN ADULT STEM CELL 2017-2025 ($ MILLION)
FIGURE 9 NORTH AMERICA STEM CELL MARKET IN HUMAN EMBRYONIC STEM CELL 2017-2025 ($ MILLION)
FIGURE 10 NORTH AMERICA STEM CELLS MARKET IN INDUCED PLURIPOTENT STEM CELL 2017-2025 ($ MILLION)
FIGURE 11 NORTH AMERICA STEM CELL MARKET IN RAT NEURAL STEM CELL 2017-2025 ($ MILLION)
FIGURE 12 NORTH AMERICA STEM CELL MARKET BY TECHNOLOGY 2017-2025 ($ MILLION)
FIGURE 13 NORTH AMERICA STEM CELL MARKET BY ACQUISITION 2017-2025 ($ MILLION)
FIGURE 14 NORTH AMERICA STEM CELL BONE MARROW MARKET 2017-2025 ($ MILLION)
FIGURE 15 NORTH AMERICA STEM CELL APHERESIS MARKET 2017-2025 ($ MILLION)
FIGURE 16 NORTH AMERICA STEM CELL UMBILICAL CORD BLOOD MARKET 2017-2025 ($ MILLION)
FIGURE 17 NORTH AMERICA STEM CELL PRODUCTION MARKET 2017-2025 ($ MILLION)
FIGURE 18 NORTH AMERICA STEM CELL THERAPEUTIC CLONING MARKET 2017-2025 ($ MILLION)
FIGURE 19 NORTH AMERICA IVF STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 20 NORTH AMERICA STEM CELLS CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 21 NORTH AMERICA STEM CELLS CRYOPRESERVATION MARKET 2017-2025 ($ MILLION)
FIGURE 22 NORTH AMERICA STEM CELL EXPANSION AND SUB-CULTURE MARKET 2017-2025 ($ MILLION)
FIGURE 23 NORTH AMERICA STEM CELLS MARKET BY APPLICATION 2017 & 2025 ($ MILLION)
FIGURE 24 NORTH AMERICA STEM CELLS REGENERATIVE MEDICINE MARKET 2017-2025 ($ MILLION)
FIGURE 25 NORTH AMERICA DRUG DISCOVERY AND DEVELOPMENT MARKET 2017-2025 ($ MILLION)
FIGURE 26 GEOGRAPHIC OUTLOOK 2016 & 2025 (%)
FIGURE 27 ESTIMATED NUMBER OF NOVEL CANCER CASES AND DEATHS BY GENDER IN THE U.S., 2016
FIGURE 28 NORTH AMERICA STEM CELL MARKET BY COUNTRIES 2016 & 2025 ($ MILLION)
FIGURE 29 NORTH AMERICA STEM CELL REGIONAL MARKET BREAKDOWN IN 2016 (%)
FIGURE 30 UNITED STATES (U.S.) STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 31 ESTIMATED CASES OF CANCER IN CANADA 2015
FIGURE 32 CANADA STEM CELL MARKET 2017-2025 ($ MILLION)
FIGURE 33 MARKET SHARE OF ANALYSIS OF KEY PLAYERS 2016 (%)
